Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
MDM2-p53 inhibitor
Macrocyclic lactone.
Synthetic ITC.
Allosteric inhibitor
Mycotoxin produced by Fusarium; sphingosine acy...
NPC1L1 inhibitor.
Calcineurin inhibitor.
Glycoside hydroquinone originally found in Berg...
Mycotoxin contaminant found in cereal grains.
Sesquiterpene lactone found in Thapsia, used to...
Mixture of glycopeptide bleomycin sulfate salts...
Steroid hormone, contraceptive; PR agonist.
p53 inhibitor
Hemantin inhibitor.
DP1 antagonist.
Thienylbutyl ITC analog.
PDE4 inhibitor.
CHK1 inhibitor.
DPP4 inhibitor.
NSAID; COX-1/2 inhibitor.